Ponni Subbiah

, MD, MPH

Senior Vice President, Global Head of Medical Affairs, Chief Medical Officer, ACADIA Pharmaceuticals

Ponni Subbiah, MD, MPH is Senior Vice President, Global Head of Medical Affairs and Chief Medical Officer, at Acadia Pharmaceuticals and has been with Acadia since October 2019. She is a neurologist with more than 20 years of experience leading medical and clinical research strategies across various therapeutic areas including neurology, psychiatry, opioid addiction, pain, oncology, diabetes, urology, inflammation, respiratory, and infectious diseases. Prior to joining Acadia, Dr. Subbiah was Chief Medical Officer for Indivior Inc., with responsibility for pharmacovigilance and medical affairs globally. During her previous tenure of over 15 years at Pfizer, Inc., she held various leadership roles in global medical affairs and led Pfizer’s Global Access program. Dr. Subbiah received her medical degree from Madras Medical College in Chennai, India and completed a residency in neurology at the Mayo Graduate School of Medicine in Rochester, MN. She completed a research/clinical fellowship in AIDS Neurology at Johns Hopkins University School of Medicine and earned a Master’s degree in Public Health from the Johns Hopkins Bloomberg School of Public Health in Baltimore, MD.

Read more

This Speaker's Sessions

Town Hall
Tuesday Oct. 20
2:00 PM
ET
Watch Replay
Now Live!

On the Path to 2025: Treatments and Diagnostics to Change the Trajectory of the Disease

What are the latest innovations in the drug pipeline?  How important is the need to develop diagnostics that can improve diagnosis and draw more patients into clinical trials, especially patients at high risk of Alzheimer’s? The panel will underscore the critical importance of progress on detection, diagnosis, research and treatments to stop Alzheimer’s. Key question: Will the U.S. meet our national goal of preventing and effectively treating Alzheimer's disease by 2025?

View SessionWatch Replay